Yoshinari Matsuda
Director/Board Member at HEALIOS K.K.
Network origin in Yoshinari Matsuda first degree
Entity | Entity type | Industry | |
---|---|---|---|
15
| Public Company | Pharmaceuticals: Major | 15 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Yoshinari Matsuda via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Mesa Verde Ventures LLC
Mesa Verde Ventures LLC Investment ManagersFinance Mesa Verde Ventures LLC (Mesa Verde Ventures) is a venture capital firm founded in 2006. The firm is headquartered in San Diego, California. | Investment Managers | Private Equity Investor | |
RetroSense Therapeutics LLC
RetroSense Therapeutics LLC Medical SpecialtiesHealth Technology RetroSense Therapeutics LLC provides biotechnology services. It offers gene therapies to restore vision in patients suffering from blindness due to retinitis pigmentosa and advanced dry age-related macular degeneration. The company was founded by Sean Ainsworth in 2009 and is headquartered in Ann Arbor, MI. | Medical Specialties | Director/Board Member | |
Kalyra Pharmaceuticals, Inc.
Kalyra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kalyra Pharmaceuticals, Inc. manufactures small molecule drugs. The company was founded by Brian T. Dorsey, Cam L. Garner and Kevin Bunker and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Immusoft Corp.
Immusoft Corp. Medical/Nursing ServicesHealth Services Immusoft Corp. provides disease curing services through immune cells. The firm offers ISP, gene delivery technology and lymphopoiesis culture system. The company was founded by Matthew Scholz in 2009 and is headquartered in Seattle, WA. | Medical/Nursing Services | Corporate Officer/Principal | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree | |
Tohmatsu Corp.
Tohmatsu Corp. Miscellaneous Commercial ServicesCommercial Services Part of Deloitte LLP (New York), Tohmatsu Corp. is a Japanese company that provides accounting services. The company is based in Tokyo, Japan. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
McGill University | College/University | Doctorate Degree | |
PRAP JAPAN, INC. | Miscellaneous Commercial Services | Director/Board Member | |
ASTELLAS PHARMA INC. | Pharmaceuticals: Major | Comptroller/Controller/Auditor | |
Waseda University | College/University | Undergraduate Degree | |
Astellas Pharma US, Inc.
Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma US, Inc. manufactures pharmaceutical products. It offers cardiology, dermatology, immunology, infectious diseases, and urology. The firm was founded in 2005 and is headquartered in Northbrook, IL. | Pharmaceuticals: Major | President | |
Kyushu University | College/University | Doctorate Degree | |
ATHERSYS, INC. | Biotechnology | Director/Board Member | |
Astellas US LLC
Astellas US LLC Pharmaceuticals: MajorHealth Technology Part of Astellas Pharma, Inc., Astellas US LLC is a company that manufactures and markets pharmaceutical products. The company is based in Northbrook, IL. The CEO of the company is Kenji Yasukawa. | Pharmaceuticals: Major | President | |
Aqumen Biopharmaceuticals KK
Aqumen Biopharmaceuticals KK Pharmaceuticals: MajorHealth Technology Aqumen Biopharmaceuticals KK is a holding company that provides research and development of therapeutic medicines for macular degeneration. It also develops therapeutics for diabetic retinopathy, diabetic nephropathy, adjuvants for ophthalmic surgery, and intraocular drug delivery systems. The firm's products encompass the ILM-Blue and the MembraneBlue-Dual. The company was founded by Kimihiko Fujisawa and Tadahisa Kagimoto on April 11, 2005 and is headquartered in Fukuoka, Japan. | Pharmaceuticals: Major | Chief Executive Officer | |
Nezu Asia Capital Management Ltd.
Nezu Asia Capital Management Ltd. Investment ManagersFinance Nezu Asia Capital Management Ltd. (Nezu HK) is the alternative investment management subsidiary of Nezu Group S.A.R.L., itself owned by Nezu Group LP in the US. Headquartered in Hong Kong, Nezu HK was founded in 2004 and they provide discretionary investment advisory services to separately managed accounts and a private investment fund, which is open only to certain financially sophisticated and high-net worth individuals and entities. | Investment Managers | Chief Operating Officer | |
COOKPAD INC. | Advertising/Marketing Services | Director of Finance/CFO | |
Neurelis, Inc.
Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Neurelis, Inc. operates as a specialty pharmaceutical company. It is organized to license, develop and commercialize product candidates for the treatment of central nervous system disorders with a focus on the acute treatment of epilepsy and anxiety episodes. The company was founded by Craig C. Chambliss and David F. Hale in 2007 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
SORRENTO THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
selectION, Inc.
selectION, Inc. BiotechnologyHealth Technology selectION, Inc. provides a technology platform to develop peptide blockers for ion channels. The company was founded by Andreas Klostermann and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member | |
John Molson School of Business | College/University | Masters Business Admin | |
Proteus RM LLC (Venture Capital)
Proteus RM LLC (Venture Capital) Investment ManagersFinance Proteus RM LLC (Venture Capital) (Proteus RM) is a venture capital subsidiary of Proteus RM LLC founded in 2006 by Gregory A. Bonfiglio. The firm is headquartered in Portola Valley, California. | Investment Managers | Founder | |
RAREJOB INC. | Other Consumer Services | Director/Board Member | |
Nezu Asia Capital Management (Singapore) Pte Ltd.
Nezu Asia Capital Management (Singapore) Pte Ltd. Investment ManagersFinance Nezu Asia Capital Management (Singapore) Pte Ltd. (Nezu Asia SG) is an independent hedge fund manager headquartered in Singapore. Nezu Asia SG manages long/short equity portfolios. | Investment Managers | President | |
Centre For Commercialization of Regenerative Medicine
Centre For Commercialization of Regenerative Medicine BiotechnologyHealth Technology Centre For Commercialization of Regenerative Medicine supports our partners to develop and commercialize cell and gene therapies and regenerative medicine technologies. Its services include business, technical and facilities. The company is headquartered in Toronto, Canada. | Biotechnology | Chairman Director/Board Member | |
CROSS MARKETING GROUP INC. | Advertising/Marketing Services | Director/Board Member | |
Insitut de Recherche en Immunologie et en Cancérologie
Insitut de Recherche en Immunologie et en Cancérologie Miscellaneous Commercial ServicesCommercial Services Insitut de Recherche en Immunologie et en Cancérologie develops and discovers treatment and therapies for cancers. It also engages in anticancer drug discovery chain. The company was founded in 2003 and is headquartered in Montréal, Canada. | Miscellaneous Commercial Services | Consultant / Advisor | |
NYLE INC. | Miscellaneous Commercial Services | Director/Board Member | |
FiNC Technologies, Inc.
FiNC Technologies, Inc. Other Consumer ServicesConsumer Services FiNC inc. operates as a provider of an online diet coach service. It specializes in deoxyribonucleic acid (DNA) analysis and environment inspection; and utilizes these data to create customized diet programs. The firm also operates fitness gyms, and provides online diet tutoring. It develops and operates an application that allows users to access diet programs and trainings created by the firm. The company was founded by Yuji Mizoguchi on April 11, 2012 and is headquartered in Tokyo, Japan. | Other Consumer Services | Director/Board Member | |
Kagimoto Holdings KK | President | ||
Sighregen Co., Ltd. | President Comptroller/Controller/Auditor Director/Board Member | ||
Nezu Master Strategy Feeder Ltd.
Nezu Master Strategy Feeder Ltd. Investment Trusts/Mutual FundsMiscellaneous Nezu Master Strategy Feeder Ltd. Operates as a private equity fund. The company is headquartered in Grand Cayman, Cayman Islands. | Investment Trusts/Mutual Funds | Director/Board Member | |
Muuseo, Inc.
Muuseo, Inc. Other Consumer ServicesConsumer Services Muuseo, Inc. operates museums. The private company is based in Tokyo, Japan. | Other Consumer Services | President | |
Oncternal Oncology, Inc.
Oncternal Oncology, Inc. Pharmaceuticals: MajorHealth Technology Oncternal Oncology, Inc. is a clinical-stage oncology company, which engages in the development of novel therapies for both rare and common cancers. The company was founded by Lauren Otsuki and Cam L. Garner and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
WANTEDLY, INC. | Packaged Software | Director/Board Member | |
OcuSub, Inc.
OcuSub, Inc. BiotechnologyHealth Technology OcuSub, Inc. engages biotechnology services. It specializes in eye disorder treatment. The company was founded by Mina Patel Sooch, Alan R. Meyer, and William H. Pitlick in 2018 and is headquartered in Farmington Hills, MI. | Biotechnology | Director/Board Member | |
jCyte, Inc.
jCyte, Inc. Medical/Nursing ServicesHealth Services jCyte, Inc. engages in the provision of retinal therapies. Its therapy focuses with retinitis pigmentosa, and retinal progenitor cells. The company was founded by Terry O?Neal, Henry Klassen and Jing Yang in 2012 and is headquartered in Newport Beach, CA. | Medical/Nursing Services | Corporate Officer/Principal | |
ONCTERNAL THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Healios N.A., Inc. | President Chief Executive Officer Director/Board Member | ||
ZENTALIS PHARMACEUTICALS, INC. | Biotechnology | Founder | |
OCUPHIRE PHARMA, INC. | Pharmaceuticals: Major | Chairman | |
Saisei Ventures LLC
Saisei Ventures LLC Investment ManagersFinance Saisei Ventures LLC (Saisei Ventures) is a venture capital firm founded by Jonathan Yeh in 2020. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Consultant / Advisor Director/Board Member Founder | |
Ray Therapeutics, Inc.
Ray Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Ray Therapeutics, Inc. is an American company that is developing a lead candidate, RTX-015, to treat retinitis pigmentosa, a degenerative retinal disease. Ray Therapeutics is based in an undisclosed location. The company's mission is to restore vision for people with retinal degeneration using optogenetics gene therapies. Ray Therapeutics is pursuing multiple drug development programs for a range of degenerative retinal diseases, focusing on preserving and restoring vision in patients using the ground-breaking science of optogenetics. The company was founded by Paul Bresge and Sean Ainsworth, with Paul Bresge serving as CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member | |
PowerX, Inc.
PowerX, Inc. Miscellaneous Commercial ServicesCommercial Services PowerX, Inc. is a Japanese next-generation energy company that aims to build a new energy grid of renewable energy storage. The company is based in Minato-ku, Japan, and the CEO of the company is Masahiro Ito. The company will construct a large-scale storage battery factory to manufacture and sell battery products that realize the explosive spread of natural energy. The PowerX ship battery is a safe and secure product that uses LFP, which is a safe and long-life battery. The battery can be installed in racks and provided as a large-capacity type of the industry-standard 10 or 20ft container type. With PowerX's large industrial storage battery mega power, businesses can significantly reduce their electricity bills. The company's solution can be introduced right now and will be available for shipping from 2023. | Miscellaneous Commercial Services | Chairman | |
Ryne Biotechnology, Inc.
Ryne Biotechnology, Inc. BiotechnologyHealth Technology Ryne Biotechnology, Inc. is an American US-based biotechnology company that focuses on developing next-generation approaches to cure neurological disorders. The company utilizes induced pluripotent stem cell (iPSC) technology to advance its off-the-shelf neuron replacement therapeutics. Ryne Bio is dedicated to advancing a pipeline targeting neurological diseases by focusing on an iPSC technology platform and forging partnerships with leaders in surgical delivery and clinical development. | Biotechnology | Founder |
Statistics
International
United States | 26 |
Japan | 18 |
Canada | 5 |
Hong Kong | 2 |
Singapore | 2 |
Sectoral
Health Technology | 19 |
Commercial Services | 10 |
Consumer Services | 9 |
Finance | 6 |
Technology Services | 3 |
Operational
Director/Board Member | 58 |
Corporate Officer/Principal | 28 |
Independent Dir/Board Member | 13 |
President | 12 |
Chairman | 11 |
Most connected contacts
Insiders | |
---|---|
Cam Gallagher | 24 |
Gregory Bonfiglio | 16 |
Jun Narimatsu | 12 |
Michael J. Alfant | 10 |
Hiromitsu Ogawa | 10 |
Al Reaves | 9 |
Hardy Kagimoto | 9 |
Jonathan Yeh | 8 |
Richard Kincaid | 7 |
Seigo Kashii | 5 |
Kouichi Tamura | 2 |
Masanori Sawada | 2 |
Michihisa Nishiyama | 1 |
David W. Smith | 1 |
Koji Abe | 1 |
- Stock Market
- Insiders
- Yoshinari Matsuda
- Company connections